Publication
VH1-69 Utilizing Antibodies Are Capable of Mediating Non-neutralizing Fc-Mediated Effector Functions Against the Transmitted/Founder gp120
Downloadable Content
- Persistent URL
- Last modified
- 05/21/2025
- Type of Material
- Authors
- Language
- English
- Date
- 2019-01-15
- Publisher
- Frontiers Media
- Publication Version
- Copyright Statement
- © 2019 Smith, Burton, Kilembe, Lakhi, Karita, Price, Allen and Derdeyn.
- License
- Final Published Version (URL)
- Title of Journal or Parent Work
- ISSN
- 1664-3224
- Volume
- 9
- Start Page
- 3163
- End Page
- 3163
- Grant/Funding Information
- This work was facilitated by the Emory Vaccine Center Flow Core of the Center for AIDS Research at Emory University (P30AI050409).
- This study was made possible through samples and data collected as part of the Zambia-Emory HIV Research Project (ZEHRP), Project San Francisco (PSF), the Rwanda Zambia HIV Research Group (RZHRG) at Emory University, and the International AIDS Vaccine Initiative (IAVI) Protocol C Research Network.
- This study was funded by NIH R01 AI-58706 (CD) and NIH R01 AI-128837 (CD).
- This work was funded in part by IAVI and made possible by the support of many donors, including United States Agency for International Development (USAID).
- Supplemental Material (URL)
- Abstract
- Multiple antibody effector functions arise in HIV-1 infection that could be harnessed to protect against infection or clear the persistent reservoir. Here, we have investigated the genetic and functional memory B cell and antibody landscape present during early infection in six individuals infected with either subtype A, C, or an A/C recombinant HIV-1. These individuals demonstrated varying levels of plasma autologous neutralization (nAb) against the transmitted/founder envelope (T/F Env) pseudovirus and non-neutralizing Fc-mediated effector function (nnFc) antibody-dependent cell-mediated cytotoxicity (ADCC) against the T/F Env gp120 protein at ~7 months after infection. Genetic analysis of the immunoglobulin heavy (VH) and light (VL) chain variable domain gene segments from 352 autologous T/F Env gp120-specific single B cells recovered at this same 7-month time-point revealed an over-representation of the VH1-69 germline in five of six individuals. A defining feature of the VH1-69 utilizing gp120-specific antibodies was their significantly more hydrophobic complementarity-determining region-2 (CDRH2) regions compared to other VH CDRH2 sequences from each individual. While none of the VH1-69 antibodies possessed strong neutralizing activity against virions pseudotyped with the autologous T/F Env, almost a third were capable of mediating high ADCC activity, as assayed by intracellular granzyme B activity in CEM.NKr.CCR5 target cells coated with autologous T/F Env gp120. High ADCC mediating VH1-69 antibodies exhibited shorter complementarity-determining region-3 (CDRH3) lengths and a more neutral isoelectric point than antibodies lacking this function. In the individual that developed the highest autologous ADCC responses, the high granzyme B producing antibodies bound to surface expressed envelope in the absence of CD4 and were not enhanced by the addition of soluble CD4. Overall, VH1-69 utilizing antibodies are commonly induced against gp120 in diverse HIV-1 infections and a subset of these antibodies can mediate ADCC functions, serving as a bridge between the innate and adaptive immune response to HIV-1.
- Author Notes
- Keywords
- gp120
- RHESUS MACAQUES
- Science & Technology
- HIV-1
- HUMAN MONOCLONAL-ANTIBODIES
- NEUTRALIZING ANTIBODY
- IMMUNODEFICIENCY-VIRUS TYPE-1
- TYROSINE SULFATION
- GAMMA RIIIA
- Immunology
- ENVELOPE GLYCOPROTEIN
- DEPENDENT CELLULAR CYTOTOXICITY
- neutralization
- V3 DOMAIN
- BINDING SITE
- VH1-69
- Life Sciences & Biomedicine
- non-neutralizing Fc-mediated effector function
- Research Categories
- Health Sciences, Epidemiology
- Health Sciences, Public Health
- Health Sciences, Immunology
Tools
- Download Item
- Contact Us
-
Citation Management Tools
Relations
- In Collection:
Items
| Thumbnail | Title | File Description | Date Uploaded | Visibility | Actions |
|---|---|---|---|---|---|
|
|
Publication File - tnb9d.pdf | Primary Content | 2025-03-24 | Public | Download |